在最近的交易中，Bolt Biotherapeutics（BOLT.us）股票出现了明显的异动，其股价在午盘时急速下跌5.20%，报0.474美元/股，成交量达6.1873万股，换手率为0.16%。同时，该股的振幅为4.00%。对比之下，生物技术行业整体仅下跌0.55%，显示Bolt Biotherapeutics的表现显著逊色于同业。值得注意的是，市场中其他相关个股如Conduit ...

北京时间2025年02月08日02时17分，Bolt Biotherapeutics（BOLT.us）股票出现异动，股价急速下跌5.20%。截至发稿，该股报0.474美元/股，成交量6.1873万股， 换手率 0.16%，振幅4.00%。

Nov. 07, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the tre REDWOOD CITY, Calif., Sept.

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...